Inicio › Cáncer de pulmón › Míchigan

Ensayos clínicos de Cáncer de pulmón en Míchigan

45 estudios sobre Cáncer de pulmón buscan participantes en Míchigan.

Ciudades en Míchigan

Texto oficial del estudio (inglés)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0418, Ann Arbor
Local Institution - 0405, Detroit
Local Institution - 0420, Traverse City

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Corewell Health - Butterworth Hospital, Grand Rapids
Corewell Health - Lemmen Holton Cancer Pavilion, Grand Rapids
Corewell Health - Research Specimen Processing Area, Grand Rapids
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

University of Michigan Rogel Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
y 38 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Bronson Battle Creek, Battle Creek
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
y 49 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Bronson Battle Creek, Battle Creek
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
y 21 más

ReclutandoFase 3

Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

University of Michigan, Ann Arbor

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

The Vanguard Study: Testing a New Way to Screen for Cancer

Henry Ford Cancer Institute-Downriver, Brownstown
Henry Ford Health Center - Brownstown, Brownstown
Henry Ford Health Center - Chesterfield, Chesterfield
y 13 más

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Henry Ford Cancer Institute, Detroit

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Profound Research, LLC, Farmington Hills

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
y 71 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health Medical Center - Brighton, Brighton
y 27 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0119, Ann Arbor

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07492680

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Michigan, Ann Arbor
The Cancer & Hematology Centers, Grand Rapids

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

START Midwest, LLC, Grand Rapids

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07903415

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Henry Ford Cancer Institute, Detroit

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07185997

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

University of Michigan, Ann Arbor

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07499674

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT02984761

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Karmanos Cancer Institute, Detroit

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06244771

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
y 4 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07393555

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Karmanos Cancer Institiute, Detroit

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Profound Research LLC at Michigan Hematology and Oncology Consultants, Dearborn
Henry Ford Health System, Detroit

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07128199

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health Medical Center - Brighton, Brighton
y 14 más

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
y 7 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

A Study of ZW251 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07164313

A Registry for People With Lung Cancer

University of Michigan (Data Collection Only), Ann Arbor

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06424327

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

START Midwest, Grand Rapids

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

University of Michigan Medical School Rogel Cancer Center, Ann Arbor

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

START Midwest, Grand Rapids

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07349537

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Henry Ford Cancer - Detroit, Detroit

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Wayne State University/Karmanos Cancer Institute, Detroit
Weisberg Cancer Treatment Center, Farmington Hills
McLaren Cancer Institute-Flint, Flint
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
McLaren Cancer Institute-Bay City, Bay City
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
y 41 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT05592626

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

START - Midwest, Grand Rapids

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07444814

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Henry Ford Cancer- Detroit, Detroit

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT07339059

Gilteritinib for the Treatment of ALK NSCLC

University of Michigan Comprehensive Cancer Center, Ann Arbor

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 jun 2026 · NCT06225427

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Karmanos Cancer Institute, Detroit

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 26 jun 2026 · NCT04614103

Prediction Augmented Screening Initiative

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

Reclutando

Edades de 50 a 80 · Todos los sexos · Actualizado el 26 jun 2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health Medical Center - Brighton, Brighton
y 19 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.